Autor: |
Korell F; Department of Hematology and Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA., DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Schreck N; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Luft T; Department of Hematology and Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. Thomas.Luft@med.uni-heidelberg.de. |